JPMorgan Resumes Bioventus Inc (BVS) at Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts BVS Hot Sheet
Price: $11.77 +7.49%
Rating Summary:
5 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 24 | New: 12
Rating Summary:
5 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 24 | New: 12
Join SI Premium – FREE
JPMorgan analyst Robbie Marcus resumes coverage on Bioventus Inc (NASDAQ: BVS) with a Overweight rating and a price target of $25.00.
For an analyst ratings summary and ratings history on Bioventus Inc click here. For more ratings news on Bioventus Inc click here.
Shares of Bioventus Inc closed at $16.58 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bioventus Inc (BVS) PT Lowered to $16 at Craig-Hallum
- Guggenheim Starts Lockheed Martin (LMT) at Buy
- UBS Starts Orbbec Inc (688322:CH) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
